Gene Query: PLAGL1

Dataset Description Geneva Score
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 83.12
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 68.84
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 67.68
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 63.92
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 59.89
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 59.51
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 58.29
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 47.02
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 47.02
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 46.47
Role of FGFR1 in neuronal devlopment 44.33
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 41.18
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 41.18
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 38.89
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 37.78
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 37.78
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 37.66
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 36.89
Differential gene expression profiles in imatinib-resistant cell lines 34.34
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 34.11
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 33.91
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 32.06
A role for ZNF598 in post-transcriptional gene regulation 29.62
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 27.69
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 27.69
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 27.52
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 27.5
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 27.5
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 27.28
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 26.51
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 26.48
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 26.09
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 25.5
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 24.96
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 24.63
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 24.63
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 24.34
Genome wide expression change by RNF168 knocking down in NEC cells 23.38
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 22.64
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 22.2
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 21.11
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 20.83
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 20.45
Transcriptomic profiling of human peripheral blood-derived mast cells 20.45
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 20.11
Effect of mitochondria deficiency on senescence-associated gene expression 19.95
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 19.92
Gene expression analysis in response to hypoxic pathway inhibition 19.84
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 19.64
Identification of the role of polydom in neurofibromas 19.43
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 18.6
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 18.23
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 18.04
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 17.92
SRSF2 mutations impair hematopoiesis and alter exon recognition 17.58
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 17.47
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 17.47
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 17.28
Irf9 function in immunity in mouse 17.28
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 17.24
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 17.01
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 16.79
Role of CD133 molecule in WNT response and renal repair 16.71
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 16.56
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 16.47
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 16.41
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 15.91
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 15.86
PNET animal model: new insights (II) 15.81
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 15.6
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 15.47
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  15.43
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 15.18
Cerebellar differentiation in Ataxia-Telangiectasia 15.17
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 14.97
RNA sequencing analysis of human embryonic stem cells and axial progenitors 14.96
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 14.92
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 14.92
Maturation of human iNSCs 14.77
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 14.61
MARS Seq data from human cortical organoids 14.5
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 14.43
BCL11B 14.34
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 14.23
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 14.18
Transcriptome analyses of human pancreatic islets and pseudoislets 14.16
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 14.13
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 14.13
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 14.12
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 14.08
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 14.08
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 14.07
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 14.01
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 13.74
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 13.69
RNA-seq analyisis of PUM2 knockout cells 13.64
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.63
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 13.58
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 13.35
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 13.33
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 13.32
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 13.32
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 13.29
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 13.29
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 13.23
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 13.17
Lysine benzoylation is a novel histone mark 13.11
Lysine benzoylation is a novel histone mark [RNA-seq] 13.11
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 13.08
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 13.06
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 13.04
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 13.01
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 12.96
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 12.95
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 12.81
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 12.76
Gene expression profile of human placenta from T. Cruzi infected mothers 12.69
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 12.61
Gene expression analysis of the impact of TDP-43 knockout in human cells. 12.56
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 12.56
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 12.52
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 12.32
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 12.3
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 12.03
U2AF1 mutations alter splice site recognition in hematological malignancies 11.96
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 11.66
Mutational landscape of splicing genes and functional consequences across 33 cancer types 11.63
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 11.59
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 11.57
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 11.56
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 11.54
Subtle asymmetry of gene expression in embryonic and foetal human brains 11.37
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 11.32
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 11.3
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 11.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.23
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.23
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 11.1
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 11.08
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 11.05
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 11.03
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 10.96
RNA-seq data from human lymphoma cell lines 10.89
ChIP-seq and RNA-seq from human lymphoma cell lines 10.89
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 10.84
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 10.84
Statins modulate endothelial transcriptional profile by inhibiting EZH2 10.81
Evolution of a transcriptional regulator from a transmembrane nucleoporin 10.61
RNA-seq in HepG2 and IMR90 cells 10.61
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 10.61
MicroRNA-125a-5p overexpression in human macrophages 10.6
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 10.59
RNA sequencing of GlyH-101-treated MCF-7 cell line 10.57
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 10.57
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 10.57
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 10.49
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.35
FOXP2's impact on the primate transcriptome 9.92
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 9.91
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.65
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.65
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 9.53
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 9.52
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 9.52
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 9.52
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 9.47
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 9.46
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.34
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.34
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 9.26
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 9.25
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 9.23
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 9.22
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 9.22
U1 snRNP telescripting regulates size-function stratified human genome 9.14
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 9.12
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 9.11
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 9.11
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 8.99
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 8.99
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.98
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 8.95
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.91
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 8.77
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 8.77
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.75
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 8.74
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 8.74
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 8.68
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 8.64
Single-nucleotide-resolution mapping of HBV promoters using CAGE 8.57
Identification of global regulators of T-helper cell lineage specification 8.53
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.53
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 8.52
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 8.48
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 8.46
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 8.42
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.42
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 8.4
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 8.4
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 8.23
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 8.21
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 8.16
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 8.15
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 8.12
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 8.09
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 8.01
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.96
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 7.89
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 7.86
In situ CAPTURE of chromatin interactions by biotinylated dCas9 7.82
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 7.82
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.76
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.72
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 7.72
Transcriptome analysis of human lung epithelial cells 7.71
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.7
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.67
CD74 role in transcription regulation 7.61
CD74 role in transcription regulation [RNA-seq] 7.61
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.61
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.61
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 7.49
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 7.47
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.46
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 7.41
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.37
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 7.34
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 7.34
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.32
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 7.31
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 7.24
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.2
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.2
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.18
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 7.18
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.17
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.08
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 7.04
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.03
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 7.02
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 6.99
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 6.97
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 6.97
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.94
Tracking of dCas9-methyltransferase footprints 6.92
Single-Cell Genotyping of Transcriptomes 6.85
RNA-seq of Single-Cell Genotyping of Transcriptomes 6.85
In vitro modeling of human germ cell development using pluripotent stem cells 6.83
X-Ray induced DNA-Hydroxymethylation changes 6.81
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.78
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 6.76
Neurofibroma 6.76
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.74
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.71
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.65
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.65
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 6.59
TFAP2C signalling in human fibroblasts 6.57
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 6.55
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.55
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.55
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.51
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.51
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.49
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.49
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 6.49
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 6.49
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 6.48
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 6.48
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 6.47
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 6.43
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.42
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.42
Transcriptional profiling of microglia; current state of the art and future perspectives 6.42
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 6.39
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 6.39
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 6.37
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.36
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.36
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.33
Transcriptomes in healthy and CHB fetal hearts 6.33
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 6.12
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 6.12
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 6.11
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 6.09
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.03
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 6.01
Transcriptome sequencing of K-562 cells 6.0
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 6.0
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.94
Random mono-allelic expression in MECP2-mutated cells 5.93
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 5.91
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.87
Transcription elongation regulates genome 3D structure 5.83
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.8
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 5.68
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 5.68
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 5.64
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 5.61
Total RNA sequencing of WT intestinal orgaonids. 5.55
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 5.52
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 5.43
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.43
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.43
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 5.38
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 5.38
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 5.38
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.36
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.35
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.28
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.25
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.2
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 5.18
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 5.15
RNA-seq of CD33 KO and control HSPCs 5.05
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.05
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 4.92
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 4.84
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 4.83
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.83
CUREfast: Accelerating research with families 4.78
4.78
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 4.75
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.73
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.73
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.73
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 4.73
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 4.72
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.72
Primate-specific gene TMEM14B promotes cortical expansion and folding 4.71
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.68
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 4.66
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.58
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.57
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.52
KLF6-dependent transcription in renal cancer cells 4.52
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 4.44
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.42
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.38
Discovering human diabetes-risk gene function with genetics and physiological assays 4.28
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.27
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.27
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 4.27
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 4.23
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 4.21
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.2
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.16
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.15
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.15
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.15
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 4.13
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.08
RNA-sequencing 4.06
BI Human Reference Epigenome Mapping Project 3.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.91
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.9
Expression profiles of the four human major ectodermal lineages 3.85
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 3.84
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.82
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 3.81
RNA-seq data 3.79
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.77
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.76
RNA-Seq in PWS iPSC-derived neurons 3.76
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.68
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.63
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.52
Transcriptome analysis of SKI knock-out in HL60 cells 3.52
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 3.48
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.47
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.47
RNA Seq of HMVEC under hypoxia 3.46
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.46
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.44
Dynamic 3D chromosomal landscapes in acute leukemia 3.44
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.43
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 3.4
Endometrial transcriptome and PGR cistrome in cycling fertile women 3.4
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.26
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 3.23
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.18
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.18
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.13
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.08
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.08
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.07
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 3.06
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.04
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.94
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 2.93
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 2.9
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.88
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.85
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.85
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.85
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.85
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.8
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.8
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.78
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.78
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.74
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.61
Loss of endometrial plasticity in recurrent pregnancy loss 2.61
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.61
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.59
Engineering Patient-Specific Tissue Implants 2.57
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.55
Bone marrow derived human B cells [normal proB] 2.55
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.53
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.42
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.42
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 2.38
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 2.37
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 2.35
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.15
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.15
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.07
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.03
Glucose inhibits cardiac maturation through nucleotide biosynthesis 2.02
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.01
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.01
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.01
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.94
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 1.88
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.83
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.82
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.82
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.77
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.75
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.75
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.75
The cytokine environment influence on human skin-derived T cells 1.66
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.65
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.65
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.57
STX4 Over-Expression in Human islets 1.55
Identification of long noncoding RNAs in T-ALL cell lines 1.49
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.46
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.45
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.44
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.44
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.43
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.43
Deep RNA sequencing of the human placental transcriptome 1.38
The transcriptome of Kawasaki Disease arteritis 1.32
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.25
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.25
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 1.24
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.19
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.16
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.13
RNA expression analysis upon JMJD1C depletion 1.13
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.13
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.12
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 1.12
Downregulation of LATS kinases alters p53 to promote cell migration 1.07
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.04
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.04
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.97
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.96
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.92
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.92
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 0.85
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.83
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.82
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.82
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.78
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.74
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.73
The role of CFTR in islet function 0.73
The Genomic Landscape of Atypical Fibroxanthoma 0.69
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.63
Gene expression changes due to PARP knockdown in human cells 0.61
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.58
hNSCs siRNA NOVA2 0.55
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.51
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.51
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.46
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.43
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.38
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.35
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.27
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.26
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.25
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.25
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.22
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.21
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.15
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.14
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.14
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 0.14
Leucegene: ALL sequencing 0.11
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.1
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.1
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.1
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.04
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation